Open access
Open access
Powered by Google Translator Translator

Archives

Cohort study: SARS-CoV-2 infection rates of antibody-positive vs. antibody-negative health-care workers – previous infection was associated with 84% lower risk of (re)infection

12 Apr, 2021 | 01:30h | UTC

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) – The Lancet

Commentary: Correlates of protection from SARS-CoV-2 infection – The Lancet

 

Commentary on Twitter

 


Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.

13 Apr, 2021 | 05:23h | UTC

They Tested Negative for Covid. Still, They Have Long Covid Symptoms. – Kaiser Health News

 

Commentary on Twitter

 


Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients

12 Apr, 2021 | 01:23h | UTC

Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients – Critical Care

 

Commentary on Twitter

 


[Preprint] Pfizer vaccine less effective for SARS-CoV-2 variant B.1.351

12 Apr, 2021 | 01:26h | UTC

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals – medRxiv

Commentaries: South African variant may evade protection from Pfizer vaccine, Israeli study says – Reuters AND Israeli data shows South African variant able to ‘break through’ Pfizer vaccine – The Times of Israel

Related: Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination AND SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination AND B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well.

 


Another study shows intravenous radiocontrast use is not associated with reduced kidney function

12 Apr, 2021 | 00:44h | UTC

Association of Intravenous Radiocontrast With Kidney Function: A Regression Discontinuity Analysis – JAMA Internal Medicine

Commentaries: Radiocontrast Exposure Safe for Kidney Function – HCP Live AND Exposure to contrast on CTPA doesn’t cause long-term kidney injury – AuntMinnie

Related: ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated” (Guideline and commentaries)

 

Commentary on Twitter (thread – click for more)

 


AHA Policy Statement: Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030

12 Apr, 2021 | 00:48h | UTC

Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association – Circulation

Commentary: AHA issues policy statement on reducing lower-extremity amputations – ACP Diabetes AND AHA Seeks to Drive Down Amputations 20% by 2030 – TCTMD

 


M-A: Treatment for bleeding esophageal varices in people with decompensated liver cirrhosis

12 Apr, 2021 | 00:39h | UTC

Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis – Cochrane Library

Summary: Treatment for bleeding from enlarged veins in the oesophagus (food pipe) in people with advanced scarring of the liver – Cochrane Library

Related Cochrane Reviews: M-A: Secondary prevention of variceal bleeding in adults with previous esophageal variceal bleeding due to decompensated liver cirrhosis AND Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis – Cochrane Library

 


Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group

12 Apr, 2021 | 00:37h | UTC

Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group – British Journal of Sports Medicine

 

Commentary on Twitter

 


[Preprint] Efficacy and safety of CoronaVac in healthcare professionals in Brazil

12 Apr, 2021 | 01:17h | UTC

Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study – SSRN

 

Commentary on Twitter (thread – click for more)

https://twitter.com/hildabast/status/1381366467665391619

 


Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents

12 Apr, 2021 | 00:36h | UTC

Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents – Science Advances

 

Commentary onTwitter

 


RCT: Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

9 Apr, 2021 | 03:18h | UTC

Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial – JAMA Neurology

Author Interview: Effect of High-Frequency (10 kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

 

Commentary on Twitter

 


Consensus Document: Management of ureteric and bladder injury

12 Apr, 2021 | 00:29h | UTC

British Association of Urological Surgeons (BAUS) consensus document: Management of ureteric and bladder injury – BJU International

 


Viewpoint | Reducing Low-Value Care and Improving Health Care Value

9 Apr, 2021 | 03:23h | UTC

Reducing Low-Value Care and Improving Health Care Value – JAMA (free for a limited period)

 


Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine

12 Apr, 2021 | 01:20h | UTC

Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine – TCTMD

Study 1: Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination – New England Journal of Medicine

Study 2: Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination – New England Journal of Medicine

 


Japanese doctors perform world’s first living donor lung transplant to a Covid-19 patient

12 Apr, 2021 | 01:12h | UTC

Japanese doctors perform world’s first living donor lung transplant to a Covid-19 patient – CNN

 


EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine

12 Apr, 2021 | 01:18h | UTC

EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine – Health Policy Watch

See also: Johnson & Johnson’s COVID-19 vaccine under scrutiny at EMA after 4 ‘serious cases’ of unusual blood clots – Fierce Pharma AND J&J COVID-19 vaccine under EU review over blood clots, AstraZeneca probe grows – Reuters

 


Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil

12 Apr, 2021 | 01:14h | UTC

Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil – Science

Original study: [Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil (study and commentary on Twitter)

 


Guidelines of care for the management of actinic keratosis

9 Apr, 2021 | 03:20h | UTC

Guidelines of care for the management of actinic keratosis – Journal of the American Academy of Dermatology

 


Short Review | How to use antihistamines

9 Apr, 2021 | 03:13h | UTC

How to use antihistamines – Canadian Medical Association Journal

 


AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude

9 Apr, 2021 | 03:33h | UTC

AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude – The BMJ

 


A guide to Plan S: the open-access initiative shaking up science publishing

9 Apr, 2021 | 03:11h | UTC

A guide to Plan S: the open-access initiative shaking up science publishing – Nature

Related: Open-access Science Funders Announce Price Transparency Rules for Publishers (several resources on the subject) AND A new mandate highlights costs, benefits of making all scientific articles free to read – Science

 


Comprehensive Review | Pneumonia

9 Apr, 2021 | 03:14h | UTC

Pneumonia – Nature Reviews Disease Primers (free for a limited period)

Try this link if the above is paywalled.

 


ESC Position Statement: Diagnosis and treatment of cardiac amyloidosis

8 Apr, 2021 | 08:49h | UTC

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases – European Heart Journal

 

Commentary on Twitter (thread – click for more)

 


Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19

12 Apr, 2021 | 01:24h | UTC

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial – The Lancet Respiratory Medicine

Commentary: Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 – The Lancet Respiratory Medicine

 

Commentary on Twitter

 


RCT: New shorter regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease

8 Apr, 2021 | 08:47h | UTC

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial – The Lancet Infectious Diseases

Commentary: Chagas disease: Shorter treatment just as effective as longer one, according to study in Bolivia published by The Lancet – Drugs for Neglected Diseases Initiative

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.